Hamacher K - Search Results

1

Distribution of 5HT2A receptors in the human brain: comparison of data in vivo and post mortem.

Forutan F, Estalji S, Beu M, Nikolaus S, Hamacher K, Coenen HH, Vosberg H, Müller-Gärtner HW, Larisch R. Forutan F, et al. Among authors: hamacher k. Nuklearmedizin. 2002;41(4):197-201. Nuklearmedizin. 2002. PMID: 12224404

2

Influence of synaptic serotonin level on [18F]altanserin binding to 5HT2 receptors in man.

Larisch R, Klimke A, Hamacher K, Henning U, Estalji S, Hohlfeld T, Vosberg H, Tosch M, Gaebel W, Coenen HH, Müller-Gärtner HW. Larisch R, et al. Among authors: hamacher k. Behav Brain Res. 2003 Feb 17;139(1-2):21-9. doi: 10.1016/s0166-4328(01)00412-0. Behav Brain Res. 2003. PMID: 12642173 Clinical Trial.

3

Disturbance of serotonin 5HT2 receptors in remitted patients suffering from hereditary depressive disorder.

Larisch R, Klimke A, Mayoral F, Hamacher K, Herzog HR, Vosberg H, Tosch M, Gaebel W, Rivas F, Coenen HH, Müller-Gärtner HW. Larisch R, et al. Among authors: hamacher k. Nuklearmedizin. 2001 Aug;40(4):129-34. Nuklearmedizin. 2001. PMID: 11556203

4

Whole-body distribution and dosimetry of O-(2-[18F]fluoroethyl)-L-tyrosine.

Pauleit D, Floeth F, Herzog H, Hamacher K, Tellmann L, Müller HW, Coenen HH, Langen KJ. Pauleit D, et al. Among authors: hamacher k. Eur J Nucl Med Mol Imaging. 2003 Apr;30(4):519-24. doi: 10.1007/s00259-003-1118-0. Epub 2003 Feb 15. Eur J Nucl Med Mol Imaging. 2003. PMID: 12589478

5

PET with O-(2-18F-Fluoroethyl)-L-Tyrosine in peripheral tumors: first clinical results.

Pauleit D, Stoffels G, Schaden W, Hamacher K, Bauer D, Tellmann L, Herzog H, Bröer S, Coenen HH, Langen KJ. Pauleit D, et al. Among authors: hamacher k. J Nucl Med. 2005 Mar;46(3):411-6. J Nucl Med. 2005. PMID: 15750152 Free article. Clinical Trial.

6

Noninvasive assessment of regional cardiac adenosine using positron emission tomography.

Deussen A, Henrich M, Hamacher K, Borst MM, Herzog H, Coenen HH, Stöcklin G, Feinendegen LE, Schrader J. Deussen A, et al. Among authors: hamacher k. J Nucl Med. 1992 Dec;33(12):2138-44. J Nucl Med. 1992. PMID: 1460505 Free article.

7

Whole-body kinetics and dosimetry of cis-4-[(18)F]fluoro-L-proline.

Börner AR, Langen KJ, Herzog H, Hamacher K, Müller-Mattheis V, Schmitz T, Ackermann R, Coenen HH. Börner AR, et al. Among authors: hamacher k. Nucl Med Biol. 2001 Apr;28(3):287-92. doi: 10.1016/s0969-8051(00)00198-0. Nucl Med Biol. 2001. PMID: 11323239

8

Differential uptake of O-(2-18F-fluoroethyl)-L-tyrosine, L-3H-methionine, and 3H-deoxyglucose in brain abscesses.

Salber D, Stoffels G, Pauleit D, Oros-Peusquens AM, Shah NJ, Klauth P, Hamacher K, Coenen HH, Langen KJ. Salber D, et al. Among authors: hamacher k. J Nucl Med. 2007 Dec;48(12):2056-62. doi: 10.2967/jnumed.107.046615. Epub 2007 Nov 15. J Nucl Med. 2007. PMID: 18006612 Free article.

9

O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours.

Weckesser M, Langen KJ, Rickert CH, Kloska S, Straeter R, Hamacher K, Kurlemann G, Wassmann H, Coenen HH, Schober O. Weckesser M, et al. Among authors: hamacher k. Eur J Nucl Med Mol Imaging. 2005 Apr;32(4):422-9. doi: 10.1007/s00259-004-1705-8. Epub 2005 Jan 14. Eur J Nucl Med Mol Imaging. 2005. PMID: 15650870 Clinical Trial.

10

No-carrier-added nucleophilic 18F-labelling in an electrochemical cell exemplified by the routine production of [18F]altanserin.

Hamacher K, Coenen HH. Hamacher K, et al. Appl Radiat Isot. 2006 Sep;64(9):989-94. doi: 10.1016/j.apradiso.2006.03.005. Epub 2006 Jul 7. Appl Radiat Isot. 2006. PMID: 16829074

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

382 results

Search Page

Filters